Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2007; 13(20): 2846-2851
Published online May 28, 2007. doi: 10.3748/wjg.v13.i20.2846
Published online May 28, 2007. doi: 10.3748/wjg.v13.i20.2846
No Fibrosis | Fibrosis | P value | |
(n = 12) | (n = 31) | ||
Sex | |||
Boys | 8 | 16 | 0.37 (NS) |
Girls | 4 | 15 | |
High ALT (n = 28) | 7 | 21 | 0.72 (NS) |
Injections (n = 11) | 2 | 9 | 0.41 (NS) |
Blood transfusion (n = 37) | 12 | 25 | 0.10 (NS) |
Frequency of transfusion | |||
Once | 2 | 6 | 0.61 (NS) |
Multiple | 10 | 19 | |
Surgical procedures (n = 8) | 4 | 4 | 0.19 (NS) |
Household contact infected with HCV (n = 1) | 0 | 1 | 0.53 (NS) |
No risk factor (n = 4) | 1 | 3 | 0.86 (NS) |
Blood disease (n = 20) | |||
Red cell aplasia | 1 | 0 | 0.14 (NS) |
Sickle cell anemia | 0 | 1 | |
Thalassemia | 8 | 10 | |
Malignancy (n = 7) | |||
ALL | 0 | 3 | NA |
Lymphoma | 0 | 4 |
- Citation: El-Hawary MA, El-Raziky MS, Esmat G, Soliman H, Abouzied A, El-Raziky M, El-Akel W, El-Sayed R, Shebl F, Shaheen AA, El-Karaksy H. Assessment of hepatic fibrosis in pediatric cases with hepatitis C virus in Egypt. World J Gastroenterol 2007; 13(20): 2846-2851
- URL: https://www.wjgnet.com/1007-9327/full/v13/i20/2846.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i20.2846